| Year |
Citation |
Score |
| 2022 |
Collingridge GL, Monaghan DT. The continually evolving role of NMDA receptors in neurobiology and disease. Neuropharmacology. 109042. PMID 35307365 DOI: 10.1016/j.neuropharm.2022.109042 |
0.543 |
|
| 2021 |
Sapkota K, Burnell ES, Irvine MW, Fang G, Gawande DY, Dravid SM, Jane DE, Monaghan DT. Pharmacological characterization of a novel negative allosteric modulator of NMDA receptors, UBP792. Neuropharmacology. 201: 108818. PMID 34610288 DOI: 10.1016/j.neuropharm.2021.108818 |
0.583 |
|
| 2020 |
Wang JX, Irvine MW, Burnell ES, Sapkota K, Thatcher RJ, Li M, Simorowski N, Volianskis A, Collingridge GL, Monaghan DT, Jane DE, Furukawa H. Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors. Nature Communications. 11: 423. PMID 31969570 DOI: 10.2210/Pdb6Uzg/Pdb |
0.57 |
|
| 2019 |
Mao Z, He S, Mesnard C, Synowicki P, Zhang Y, Chung L, Wiesman AI, Wilson TW, Monaghan DT. NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback. Brain Research. 146571. PMID 31786200 DOI: 10.1016/J.Brainres.2019.146571 |
0.444 |
|
| 2019 |
Sapkota K, Dore K, Tang K, Irvine M, Fang G, Burnell ES, Malinow R, Jane DE, Monaghan DT. The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators. Biochemical Pharmacology. 159: 140-153. PMID 30503374 DOI: 10.1016/J.Bcp.2018.11.018 |
0.523 |
|
| 2018 |
Irvine MW, Fang G, Sapkota K, Burnell ES, Volianskis A, Costa BM, Culley G, Collingridge GL, Monaghan DT, Jane DE. Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid. European Journal of Medicinal Chemistry. 164: 471-498. PMID 30622023 DOI: 10.1016/J.Ejmech.2018.12.054 |
0.498 |
|
| 2018 |
Burnell ES, Irvine MW, Fang G, Sapkota K, Jane DE, Monaghan DT. Positive and Negative Allosteric Modulators of N-Methyl-D-Aspartate (NMDA) Receptors; Structure-Activity Relationships and Mechanisms of Action. Journal of Medicinal Chemistry. PMID 29446949 DOI: 10.1021/Acs.Jmedchem.7B01640 |
0.622 |
|
| 2017 |
Chopra DA, Sapkota K, Irvine MW, Fang G, Jane DE, Monaghan DT, Dravid SM. A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors. Scientific Reports. 7: 6933. PMID 28761055 DOI: 10.1038/S41598-017-07292-8 |
0.629 |
|
| 2017 |
Sapkota K, Irvine MW, Fang G, Burnell ES, Bannister N, Volianskis A, Culley GR, Dravid SM, Collingridge GL, Jane DE, Monaghan DT. Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives. Neuropharmacology. PMID 28709671 DOI: 10.1016/J.Neuropharm.2017.07.007 |
0.591 |
|
| 2016 |
Gupta SC, Ravikrishnan A, Liu J, Mao Z, Pavuluri R, Hillman BG, Gandhi PJ, Stairs DJ, Li M, Ugale RR, Monaghan DT, Dravid SM. The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function. Scientific Reports. 6: 38321. PMID 27922130 DOI: 10.1038/Srep38321 |
0.456 |
|
| 2016 |
France G, Fernández-Fernández D, Burnell ES, Irvine MW, Monaghan DT, Jane DE, Bortolotto ZA, Collingridge GL, Volianskis A. Multiple roles of GluN2B-containing NMDA receptors in synaptic plasticity in juvenile hippocampus. Neuropharmacology. PMID 27523302 DOI: 10.1016/J.Neuropharm.2016.08.010 |
0.452 |
|
| 2015 |
Sapkota K, Mao Z, Synowicki P, Lieber D, Liu M, Ikezu T, Gautam V, Monaghan DT. GluN2D NMDAR subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine; implications for schizophrenia. The Journal of Pharmacology and Experimental Therapeutics. PMID 26675679 DOI: 10.1124/Jpet.115.230391 |
0.34 |
|
| 2015 |
Irvine MW, Fang G, Eaves R, Mayo-Martin MB, Burnell ES, Costa BM, Culley GR, Volianskis A, Collingridge GL, Monaghan DT, Jane DE. Synthesis of a Series of Novel 3,9-Disubstituted Phenanthrenes as Analogues of Known NMDA Receptor Allosteric Modulators. Synthesis. 47: 1593-1610. PMID 26568642 DOI: 10.1055/S-0034-1380114 |
0.564 |
|
| 2015 |
Chopra DA, Monaghan DT, Dravid SM. Bidirectional Effect of Pregnenolone Sulfate on GluN1/GluN2A N-Methyl-D-Aspartate Receptor Gating Depending on Extracellular Calcium and Intracellular Milieu. Molecular Pharmacology. 88: 650-9. PMID 26162866 DOI: 10.1124/Mol.115.100396 |
0.496 |
|
| 2015 |
Irvine MW, Fang G, Eaves R, Mayo-Martin MB, Burnell ES, Costa BM, Culley GR, Volianskis A, Collingridge GL, Monaghan DT, Jane DE. Synthesis of a series of novel 3,9-disubstituted phenanthrenes as analogues of known N-methyl-D-aspartate receptor allosteric modulators Synthesis (Germany). 47: 1593-1610. DOI: 10.1055/s-0034-1380114 |
0.439 |
|
| 2013 |
Gautam V, Trinidad JC, Rimerman RA, Costa BM, Burlingame AL, Monaghan DT. Nedd4 is a specific E3 ubiquitin ligase for the NMDA receptor subunit GluN2D. Neuropharmacology. 74: 96-107. PMID 23639431 DOI: 10.1016/J.Neuropharm.2013.04.035 |
0.665 |
|
| 2013 |
Volianskis A, Bannister N, Collett VJ, Irvine MW, Monaghan DT, Fitzjohn SM, Jensen MS, Jane DE, Collingridge GL. Different NMDA receptor subtypes mediate induction of long-term potentiation and two forms of short-term potentiation at CA1 synapses in rat hippocampus in vitro. The Journal of Physiology. 591: 955-72. PMID 23230236 DOI: 10.1113/Jphysiol.2012.247296 |
0.454 |
|
| 2013 |
Collingridge GL, Volianskis A, Bannister N, France G, Hanna L, Mercier M, Tidball P, Fang G, Irvine MW, Costa BM, Monaghan DT, Bortolotto ZA, Molnár E, Lodge D, Jane DE. The NMDA receptor as a target for cognitive enhancement. Neuropharmacology. 64: 13-26. PMID 22796429 DOI: 10.1016/J.Neuropharm.2012.06.051 |
0.373 |
|
| 2012 |
Monaghan DT, Irvine MW, Costa BM, Fang G, Jane DE. Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators. Neurochemistry International. 61: 581-92. PMID 22269804 DOI: 10.1016/J.Neuint.2012.01.004 |
0.561 |
|
| 2012 |
Irvine MW, Costa BM, Volianskis A, Fang G, Ceolin L, Collingridge GL, Monaghan DT, Jane DE. Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-D-aspartate receptors. Neurochemistry International. 61: 593-600. PMID 22265875 DOI: 10.1016/J.Neuint.2011.12.020 |
0.553 |
|
| 2012 |
Costa BM, Irvine MW, Fang G, Eaves RJ, Mayo-Martin MB, Laube B, Jane DE, Monaghan DT. Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid. Neuropharmacology. 62: 1730-6. PMID 22155206 DOI: 10.1016/J.Neuropharm.2011.11.019 |
0.696 |
|
| 2012 |
Irvine MW, Costa BM, Dlaboga D, Culley GR, Hulse R, Scholefield CL, Atlason P, Fang G, Eaves R, Morley R, Mayo-Martin MB, Amici M, Bortolotto ZA, Donaldson L, Collingridge GL, ... ... Monaghan DT, et al. Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors. Journal of Medicinal Chemistry. 55: 327-41. PMID 22111545 DOI: 10.1021/Jm201230Z |
0.667 |
|
| 2012 |
Monaghan DT, Buller AL. Anatomical, pharmacological, and molecular diversity of native NMDA receptor subtypes The Nmda Receptor. DOI: 10.1093/acprof:oso/9780192625021.003.0006 |
0.594 |
|
| 2011 |
Jullienne A, Montagne A, Orset C, Lesept F, Jane DE, Monaghan DT, Maubert E, Vivien D, Ali C. Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo. Molecular Neurodegeneration. 6: 68. PMID 21975018 DOI: 10.1186/1750-1326-6-68 |
0.546 |
|
| 2010 |
Costa BM, Irvine MW, Fang G, Eaves RJ, Mayo-Martin MB, Skifter DA, Jane DE, Monaghan DT. A novel family of negative and positive allosteric modulators of NMDA receptors. The Journal of Pharmacology and Experimental Therapeutics. 335: 614-21. PMID 20858708 DOI: 10.1124/Jpet.110.174144 |
0.824 |
|
| 2010 |
Suárez F, Zhao Q, Monaghan DT, Jane DE, Jones S, Gibb AJ. Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones. The European Journal of Neuroscience. 32: 359-67. PMID 20618827 DOI: 10.1111/J.1460-9568.2010.07298.X |
0.534 |
|
| 2009 |
Talbot JN, Skifter DA, Bianchi E, Monaghan DT, Toews ML, Murrin LC. Regulation of mu opioid receptor internalization by the scaffold protein RanBPM. Neuroscience Letters. 466: 154-8. PMID 19788913 DOI: 10.1016/J.Neulet.2009.09.048 |
0.76 |
|
| 2009 |
Costa BM, Feng B, Tsintsadze TS, Morley RM, Irvine MW, Tsintsadze V, Lozovaya NA, Jane DE, Monaghan DT. N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. The Journal of Pharmacology and Experimental Therapeutics. 331: 618-26. PMID 19684252 DOI: 10.1124/Jpet.109.156752 |
0.696 |
|
| 2008 |
Whitney NP, Peng H, Erdmann NB, Tian C, Monaghan DT, Zheng JC. Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2888-900. PMID 18403631 DOI: 10.1096/Fj.07-104661 |
0.426 |
|
| 2008 |
Brothwell SL, Barber JL, Monaghan DT, Jane DE, Gibb AJ, Jones S. NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones. The Journal of Physiology. 586: 739-50. PMID 18033813 DOI: 10.1113/Jphysiol.2007.144618 |
0.643 |
|
| 2006 |
Bean L, Zheng H, Patel KP, Monaghan DT. Regional variations in NMDA receptor downregulation in streptozotocin-diabetic rat brain. Brain Research. 1115: 217-22. PMID 16938282 DOI: 10.1016/J.Brainres.2006.07.090 |
0.7 |
|
| 2006 |
Maurice T, Meunier J, Feng B, Ieni J, Monaghan DT. Interaction with sigma(1) protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil. The Journal of Pharmacology and Experimental Therapeutics. 317: 606-14. PMID 16397090 DOI: 10.1124/Jpet.105.097394 |
0.618 |
|
| 2006 |
Lozovaya NA, Grebenyuk SE, Tsintsadze TS, Feng B, Monaghan DT, Krishtal OA. Extrasynaptic NR2B and NR2D subunits of NMDA receptors are shaping “superslow” afterburst EPSC in hippocampus Journal of Physiology-Paris. 99: 2-3. DOI: 10.1016/J.Jphysparis.2005.12.049 |
0.658 |
|
| 2005 |
Morley RM, Tse HW, Feng B, Miller JC, Monaghan DT, Jane DE. Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists. Journal of Medicinal Chemistry. 48: 2627-37. PMID 15801853 DOI: 10.1021/Jm0492498 |
0.579 |
|
| 2005 |
Kinarsky L, Feng B, Skifter DA, Morley RM, Sherman S, Jane DE, Monaghan DT. Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket. The Journal of Pharmacology and Experimental Therapeutics. 313: 1066-74. PMID 15743930 DOI: 10.1124/Jpet.104.082990 |
0.803 |
|
| 2005 |
Feng B, Morley RM, Jane DE, Monaghan DT. The effect of competitive antagonist chain length on NMDA receptor subunit selectivity. Neuropharmacology. 48: 354-9. PMID 15721167 DOI: 10.1016/J.Neuropharm.2004.11.004 |
0.648 |
|
| 2005 |
Shimoyama N, Shimoyama M, Davis AM, Monaghan DT, Inturrisi CE. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 312: 834-40. PMID 15388787 DOI: 10.1124/Jpet.104.074856 |
0.513 |
|
| 2005 |
Monaghan DT, More JCA, Feng B, Jane DE. Glutamate receptors ionotropic Dopamine and Glutamate in Psychiatric Disorders. 79-116. DOI: 10.1007/978-1-59259-852-6_4 |
0.578 |
|
| 2004 |
Lozovaya NA, Grebenyuk SE, Tsintsadze TSh, Feng B, Monaghan DT, Krishtal OA. Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape 'superslow' afterburst EPSC in rat hippocampus. The Journal of Physiology. 558: 451-63. PMID 15146049 DOI: 10.1113/Jphysiol.2004.063792 |
0.663 |
|
| 2004 |
Feng B, Tse HW, Skifter DA, Morley R, Jane DE, Monaghan DT. Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. British Journal of Pharmacology. 141: 508-16. PMID 14718249 DOI: 10.1038/Sj.Bjp.0705644 |
0.828 |
|
| 2003 |
Xiong H, McCabe L, Skifter D, Monaghan DT, Gendelman HE. Activation of NR1a/NR2B receptors by monocyte-derived macrophage secretory products: implications for human immunodeficiency virus type one-associated dementia. Neuroscience Letters. 341: 246-50. PMID 12697294 DOI: 10.1016/S0304-3940(03)00194-0 |
0.772 |
|
| 2000 |
Hrabetova S, Serrano P, Blace N, Tse HW, Skifter DA, Jane DE, Monaghan DT, Sacktor TC. Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: RC81. PMID 10827202 DOI: 10.1523/Jneurosci.20-12-J0002.2000 |
0.807 |
|
| 2000 |
Glover RT, Angiolieri M, Kelly S, Monaghan DT, Wang JY, Smithgall TE, Buller AL. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase. The Journal of Biological Chemistry. 275: 12725-9. PMID 10777567 DOI: 10.1074/Jbc.275.17.12725 |
0.412 |
|
| 2000 |
Christie JM, Jane DE, Monaghan DT. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites. The Journal of Pharmacology and Experimental Therapeutics. 292: 1169-74. PMID 10688637 |
0.645 |
|
| 1999 |
Christie JM, Wenthold RJ, Monaghan DT. Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus. Journal of Neurochemistry. 72: 1523-8. PMID 10098857 DOI: 10.1046/J.1471-4159.1999.721523.X |
0.532 |
|
| 1998 |
Monaghan DT, Andaloro VJ, Skifter DA. Molecular determinants of NMDA receptor pharmacological diversity. Progress in Brain Research. 116: 171-90. PMID 9932377 DOI: 10.1016/S0079-6123(08)60437-9 |
0.827 |
|
| 1998 |
Brown JC, Tse HW, Skifter DA, Christie JM, Andaloro VJ, Kemp MC, Watkins JC, Jane DE, Monaghan DT. [3H]homoquinolinate binds to a subpopulation of NMDA receptors and to a novel binding site. Journal of Neurochemistry. 71: 1464-70. PMID 9751179 DOI: 10.1046/J.1471-4159.1998.71041464.X |
0.812 |
|
| 1998 |
Thomas MP, Webster WW, Norgren RB, Monaghan DT, Morrisett RA. Survival and functional demonstration of interregional pathways in fore/midbrain slice explant cultures. Neuroscience. 85: 615-26. PMID 9622257 DOI: 10.1016/S0306-4522(97)00646-5 |
0.33 |
|
| 1998 |
Andaloro VJ, Monaghan DT, Rosenquist TH. Dextromethorphan and other N-methyl-D-aspartate receptor antagonists are teratogenic in the avian embryo model Pediatric Research. 43: 1-7. PMID 9432105 DOI: 10.1203/00006450-199801000-00001 |
0.68 |
|
| 1997 |
Willis CL, Dauenhauer DL, Humphrey JM, Chamberlin AR, Buller AL, Monaghan DT, Bridges RJ. Methylation of the NMDA receptor agonist L-trans-2,3-pyrrolidine-dicarboxylate: enhanced excitotoxic potency and selectivity. Toxicology and Applied Pharmacology. 144: 45-55. PMID 9169068 DOI: 10.1006/Taap.1997.8112 |
0.607 |
|
| 1997 |
Buller AL, Monaghan DT. Pharmacological heterogeneity of NMDA receptors: Characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes European Journal of Pharmacology. 320: 87-94. PMID 9049607 DOI: 10.1016/S0014-2999(96)00880-1 |
0.682 |
|
| 1997 |
Monaghan DT, Larsen H. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology Journal of Pharmacology and Experimental Therapeutics. 280: 614-620. PMID 9023271 |
0.604 |
|
| 1995 |
Liu L, Brown JC, Webster WW, Morrisett RA, Monaghan DT. Insulin potentiates N-methyl-D-aspartate receptor activity in Xenopus oocytes and rat hippocampus. Neuroscience Letters. 192: 5-8. PMID 7675309 DOI: 10.1016/0304-3940(95)11593-L |
0.563 |
|
| 1995 |
Buller AL, Larson HC, Morrisett RA, Monaghan DT. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Molecular Pharmacology. 48: 717-23. PMID 7476899 |
0.476 |
|
| 1994 |
Buller AL, Larson HC, Schneider BE, Beaton JA, Morrisett RA, Monaghan DT. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 5471-84. PMID 7916045 DOI: 10.1523/Jneurosci.14-09-05471.1994 |
0.695 |
|
| 1992 |
Beaton JA, Stemsrud K, Monaghan DT. Identification of a novel N-methyl-D-aspartate receptor population in the rat medial thalamus Journal of Neurochemistry. 59: 754-757. PMID 1385829 |
0.636 |
|
| 1992 |
Monaghan DT, Beaton JA. Pharmacologically-distinct NMDA receptor populations of the cerebellum, medial thalamic nuclei and forebrain Molecular Neuropharmacology. 2: 71-75. |
0.514 |
|
| 1991 |
Monaghan DT, Beaton JA. Quinolinate differentiates between forebrain and cerebellar NMDA receptors European Journal of Pharmacology. 194: 123-125. PMID 1676371 DOI: 10.1016/0014-2999(91)90134-C |
0.666 |
|
| 1991 |
Monaghan DT. Differential stimulation of [3H]MK-801 binding to subpopulations of NMDA receptors Neuroscience Letters. 122: 21-24. PMID 1676144 DOI: 10.1016/0304-3940(91)90183-T |
0.601 |
|
| 1991 |
Maler L, Monaghan D. The distribution of excitatory amino acid binding sites in the brain of an electric fish, Apteronotus leptorhynchus. Journal of Chemical Neuroanatomy. 4: 39-61. PMID 1672817 DOI: 10.1016/0891-0618(91)90031-7 |
0.486 |
|
| 1990 |
Ułas J, Monaghan DT, Cotman CW. Kainate receptors in the rat hippocampus: A distribution and time course of changes in response to unilateral lesions of the entorhinal cortex Journal of Neuroscience. 10: 2352-2362. PMID 2165522 DOI: 10.1523/Jneurosci.10-07-02352.1990 |
0.429 |
|
| 1990 |
Ułas J, Monaghan DT, Cotman CW. Plastic response of hippocampal excitatory amino acid receptors to deafferentation and reinnervation Neuroscience. 34: 9-17. PMID 2158009 DOI: 10.1016/0306-4522(90)90300-S |
0.528 |
|
| 1990 |
Anderson KJ, Monaghan DT, Bridges RJ, Tavoularis AL, Cotman CW. Autoradiographic characterization of putative excitatory amino acid transport sites Neuroscience. 38: 311-322. PMID 1979852 DOI: 10.1016/0306-4522(90)90030-8 |
0.436 |
|
| 1990 |
Watson GB, Monaghan DT, Lanthorn TH. Selective activation of oscillatory currents by trans-ACPD in rat brain mRNA-injected Xenopus oocytes and their blockade by NMDA. European Journal of Pharmacology. 179: 479-81. PMID 1694771 DOI: 10.1016/0014-2999(90)90194-B |
0.311 |
|
| 1989 |
Cotman CW, Geddes JW, Bridges RJ, Monaghan DT. N-methyl-D-aspartate receptors and Alzheimer's disease Neurobiology of Aging. 10: 603-605. PMID 2572983 DOI: 10.1016/0197-4580(89)90144-9 |
0.575 |
|
| 1989 |
Palmer E, Monaghan DT, Cotman CW. Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor European Journal of Pharmacology. 166: 585-587. PMID 2553440 DOI: 10.1016/0014-2999(89)90383-X |
0.425 |
|
| 1989 |
Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system Annual Review of Pharmacology and Toxicology. 29: 365-402. PMID 2543272 DOI: 10.1146/Annurev.Pa.29.040189.002053 |
0.484 |
|
| 1989 |
Westerberg E, Monaghan DT, Kalimo H, Cotman CW, Wieloch TW. Dynamic changes of excitatory amino acid receptors in the rat hippocampus following transient cerebral ischemia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 798-805. PMID 2538582 DOI: 10.1523/Jneurosci.09-03-00798.1989 |
0.568 |
|
| 1989 |
Cotman CW, Monaghan DT, Geddes JW. N‐methyl‐D‐aspartate receptors, synaptic plasticity, and Alzheimer's disease Drug Development Research. 17: 331-338. DOI: 10.1002/ddr.430170408 |
0.612 |
|
| 1988 |
Palmer E, Monaghan DT, Cotman CW. Glutamate receptors and phosphoinositide metabolism: stimulation via quisqualate receptors is inhibited by N-methyl-D-aspartate receptor activation Brain Research. 464: 161-165. PMID 2905924 DOI: 10.1016/0169-328X(88)90008-3 |
0.573 |
|
| 1988 |
Monaghan DT, Olverman HJ, Nguyen L, Watkins JC, Cotman CW. Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine. Proceedings of the National Academy of Sciences of the United States of America. 85: 9836-40. PMID 2904680 DOI: 10.1073/Pnas.85.24.9836 |
0.651 |
|
| 1988 |
Bridges RJ, Kadri MM, Monaghan DT, Nunn PB, Watkins JC, Cotman CW. Inhibition of [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding by the excitotoxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acid. European Journal of Pharmacology. 145: 357-9. PMID 2895006 DOI: 10.1016/0014-2999(88)90442-6 |
0.309 |
|
| 1988 |
Cotman CW, Monaghan DT, Ganong AH. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity Annual Review of Neuroscience. 11: 61-80. PMID 2452598 DOI: 10.1146/Annurev.Ne.11.030188.000425 |
0.539 |
|
| 1987 |
Westerberg E, Monaghan DT, Cotman CW, Wieloch T. Excitatory amino acid receptors and ischemic brain damage in the rat Neuroscience Letters. 73: 119-124. PMID 2881232 DOI: 10.1016/0304-3940(87)90004-8 |
0.515 |
|
| 1987 |
Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J. Anatomical organization of excitatory amino acid receptors and their pathways Trends in Neurosciences. 10: 273-280. DOI: 10.1016/0166-2236(87)90172-X |
0.596 |
|
| 1986 |
Olverman HJ, Monaghan DT, Cotman CW, Watkins JC. [3H]CPP, a new competitive ligand for NMDA receptors. European Journal of Pharmacology. 131: 161-2. PMID 3028828 DOI: 10.1016/0014-2999(86)90533-9 |
0.593 |
|
| 1986 |
Cotman CW, Monaghan DT. Anatomical organization of excitatory amino acid receptors and their properties Advances in Experimental Medicine and Biology. 203: 237-252. PMID 3024456 DOI: 10.1007/978-1-4684-7971-3_18 |
0.543 |
|
| 1986 |
Monaghan DT, Cotman CW. Identification and properties of N-methyl-D-aspartate receptors in rat brain synaptic plasma membranes Proceedings of the National Academy of Sciences of the United States of America. 83: 7532-7536. PMID 3020547 DOI: 10.1073/Pnas.83.19.7532 |
0.515 |
|
| 1986 |
Bridges RJ, Hearn TJ, Monaghan DT, Cotman CW. A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain Brain Research. 375: 204-209. PMID 3013370 DOI: 10.1016/0006-8993(86)90977-7 |
0.512 |
|
| 1986 |
Harris EW, Ganong AH, Monaghan DT, Watkins JC, Cotman CW. Action of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): a new and highly potent antagonist of N-methyl-D-aspartate receptors in the hippocampus. Brain Research. 382: 174-7. PMID 2876750 DOI: 10.1016/0006-8993(86)90128-9 |
0.606 |
|
| 1985 |
Geddes JW, Monaghan DT, Cotman CW, Lott IT, Kim RC, Chui HC. Plasticity of hippocampal circuitry in Alzheimer's disease. Science (New York, N.Y.). 230: 1179-81. PMID 4071042 DOI: 10.1126/Science.4071042 |
0.324 |
|
| 1985 |
Altschuler RA, Monaghan DT, Haser WG, Wenthold RJ, Curthoys NP, Cotman CW. Immunocytochemical localization of glutaminase-like and aspartate aminotransferase-like immunoreactivities in the rat and guinea pig hippocampus. Brain Research. 330: 225-33. PMID 3886076 DOI: 10.1016/0006-8993(85)90681-X |
0.311 |
|
| 1985 |
Monaghan DT, Cotman CW. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain Journal of Neuroscience. 5: 2909-2919. PMID 2865341 |
0.573 |
|
| 1985 |
Monaghan DT, Yao D, Cotman CW. l-[3H]Glutamate binds to kainate-, NMDA- and AMPA-sensitive binding sites: an autoradiographic analysis Brain Research. 340: 378-383. PMID 2862960 DOI: 10.1016/0006-8993(85)90936-9 |
0.421 |
|
| 1985 |
Monaghan D, Cotman C. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain The Journal of Neuroscience. 5: 2909-2919. DOI: 10.1523/JNEUROSCI.05-11-02909.1985 |
0.573 |
|
| 1984 |
Monaghan DT, Yao D, Olverman HJ, Watkins JC, Cotman CW. Autoradiography of D-2-[3H]amino-5-phosphonopentanoate binding sites in rat brain. Neuroscience Letters. 52: 253-8. PMID 6151632 DOI: 10.1016/0304-3940(84)90170-8 |
0.463 |
|
| 1984 |
Monaghan DT, Yao D, Cotman CW. Distribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiography Brain Research. 324: 160-164. PMID 6097340 DOI: 10.1016/0006-8993(84)90636-X |
0.447 |
|
| 1983 |
Monaghan DT, McMills MC, Chamberlin AR, Cotman CW. Synthesis of [3H]2-amino-4-phosphonobutyric acid and characterization of its binding to rat brain membranes: a selective ligand for the chloride/calcium-dependent class of L-glutamate binding sites. Brain Research. 278: 137-44. PMID 6640305 DOI: 10.1016/0006-8993(83)90232-9 |
0.326 |
|
| 1983 |
Monaghan DT, Holets VR, Toy DW, Cotman CW. Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites Nature. 306: 176-179. PMID 6316143 DOI: 10.1038/306176a0 |
0.549 |
|
| 1983 |
Whittemore SR, Edward Mena E, Monaghan DT, Cotman CW. Regional distribution and ionic requirement of Cl-/Ca2+-activated and Cl-/Ca2+-independent glutamate receptors in rat brain Brain Research. 277: 99-107. PMID 6315142 DOI: 10.1016/0006-8993(83)90911-3 |
0.439 |
|
| 1983 |
Fagg GE, Edward Mena E, Monaghan DT, Cotman CW. Freezing eliminates a specific population of l-glutamate receptors in synaptic membranes Neuroscience Letters. 38: 157-162. PMID 6312382 DOI: 10.1016/0304-3940(83)90033-2 |
0.301 |
|
| 1982 |
Monaghan DT, Edward Mena E, Cotman CW. The effect of entorhinal cortical ablation on the distribution of muscarinic cholinergic receptors in the rat hippocampus Brain Research. 234: 480-485. PMID 7059841 DOI: 10.1016/0006-8993(82)90891-5 |
0.366 |
|
| 1981 |
Mena EE, Monaghan DT, Cotman CW. Lesion-induced alterations of lectin binding sites in the rat dentate gyrus Neuroscience. 6: 1975-1983. PMID 7301114 DOI: 10.1016/0306-4522(81)90037-3 |
0.361 |
|
| 1981 |
Foster AC, Mena EE, Monaghan DT, Cotman CW. Synaptic localization of kainic acid binding sites Nature. 289: 73-75. PMID 6256647 DOI: 10.1038/289073a0 |
0.48 |
|
| Show low-probability matches. |